9 Patient Recruitment Companies Operating in the United Kingdom in 2026

A trial recruitment vendor's core job is finding eligible participants faster than a site could on its own — through advertising, referral networks, electronic health record screening, or specialist outreach to populations a study might otherwise miss. In the UK, that work increasingly runs through NHS primary care data and GP referral relationships alongside more familiar digital advertising and site-based recruitment centres. This kind of clinical trial recruitment service also covers retention and patient tracing, since keeping enrolled participants engaged through a study's duration matters as much as finding them in the first place.

The patient recruitment companies below, headquartered in London, Letchworth, Middlesbrough, Blackpool, and Manchester, are listed in no particular order. Between them, these companies and providers cover EHR-based patient identification, social media advertising, in-country recruitment coaching, patient tracing, and site-based recruitment centres.

ACORN IQ

ACORN IQ connects researchers with patient populations in Africa, running data-driven identification and outreach services intended to close the region's research participation gap. Founded in 2022 and based in London, the company centers its work specifically on expanding African patients' access to clinical trials rather than offering broader geographic recruitment coverage. Its services span patient identification, screening, and enrollment support, using real-world data and targeted communications to reach candidates for a study. ACORN IQ describes bridging what it calls Africa's research “disparity gap” as the driving focus behind its recruitment work.

Innovative Trials

Innovative Trials deploys what it calls “boots-on-the-ground” patient recruitment specialists in more than 70 countries, working directly with individual trial sites to address local recruitment and retention challenges in the relevant language. Founded in 2010 by CEO Kate Shaw and based in Letchworth Garden City, the company has grown to more than 60 UK staff plus roughly 65 specialists stationed overseas. In 2023 it launched Navigator, a patient-first support service that follows participants from referral through study endpoint, after successful pilot projects in the US. Innovative Trials reports experience across more than 25 therapeutic areas and 400 trials.

uMed Recruit

uMed Recruit identifies eligible patients through clinically validated criteria applied to electronic health records across its primary care network, then sends pre-screening questionnaires by SMS, email, or letter on a patient's behalf before study nurses confirm eligibility by phone. Founded in 2018 and based in London, the company reports its platform increases the average number of patients randomized per month by roughly three times compared with manual recruitment. In one published case, uMed helped a Parkinson's disease study run by Queen Mary University of London and University College London exceed 10,000 participants. The company states its outreach approach can achieve up to five times greater representation of minoritized groups than traditional recruitment methods.

Ross Jackson

Ross Jackson offers advisory and consulting services in patient recruitment and retention, working with sponsors, CROs, research sites, and solutions providers on strategy rather than running recruitment campaigns directly. Based in Middlesbrough and working in the field since 1998, Jackson is the author of two books on the subject — The Patient Recruitment Conundrum and Patient Recruitment for Clinical Trials Using Facebook Ads — the latter credited with the description “the Godfather of social media patient recruitment.” The practice has advised on more than 100 patient recruitment projects across the UK, Europe, and the US. Jackson's five-step process for client engagements covers finding, engaging, qualifying, and retaining trial participants.

nativve Health Research

nativve Health Research runs paid social media and digital advertising campaigns designed to recruit clinical trial and survey participants for academic and commercial research teams. Founded in 2014 by brothers Tim and Joe after a first project helping a struggling study recruit hard-to-reach participants, the company has since supported more than 100 research teams across the UK, US, and Australia. In one case, a University of Oxford team recruited 1,540 people within five weeks using only nativve's social media campaigns. The company markets its approach as faster and more cost-effective than traditional recruitment methods, with the ability to target specific, hard-to-reach populations.

reCharge reSearch

reCharge reSearch is a business and strategic innovation consultancy focused on clinical trial design, planning, and diverse and inclusive patient recruitment and retention. The company describes a mission to reimagine, redesign, and demystify clinical trials, aiming to remove unnecessary complexity for both healthcare professionals and patients. Its stated focus includes recharging commercial clinical trial opportunities specifically within the UK, alongside broader patient engagement solutions. reCharge reSearch draws on what it describes as global experience in clinical trial design and recruitment strategy.

LTFU Global

LTFU Global traces its roots to Intime Investigations, a fraud-investigation firm founded in 2008 that began locating clinical trial participants lost to follow-up in 2011 through what it describes as the first online platform dedicated to worldwide LTFU patient tracing. The London-based company now operates as a dedicated patient-tracing service, using data tools and human investigators to verify a participant's vital status, update contact details, and reconnect them with a trial site. LTFU Global works with contract research organizations and describes partnerships with bodies including the National Institutes of Health. The company frames patient retention as central to data integrity, since missing follow-up data can compromise a trial's validity.

MAC Clinical Research

MAC Clinical Research runs a dedicated patient recruitment and retention centre built around MAC EnVision, a proprietary engagement software suite the company uses to pre-screen and monitor patients against a study's inclusion and exclusion criteria. Founded in 2002 and headquartered in Blackpool, the company operates its own network of UK research sites — including locations in Barnsley, Liverpool, Leeds, Manchester, and Glasgow — that it says provide access to more than 30 million patients. MAC combines direct-to-patient correspondence, radio and print advertising, and social media outreach with a multi-channel contact centre to manage inbound interest. The company also operates its own laboratory offering bioanalytical services and clinical pathology support.

NorthWest EHealth

NorthWest EHealth (NWEH) piloted a new model for finding clinical trial participants in 2024, combining its FARSITE feasibility platform with the UK's Clinical Practice Research Datalink (CPRD) — a database of 18 million anonymized patient records — to run feasibility studies and find-and-refer services without transferring data between organizations. Based in Manchester, the company builds its recruitment work on electronic health record (EHR) data rather than advertising or referral networks, working with academic partners and the NHS. NWEH states the model is designed to improve the speed, scale, inclusivity, and representativeness of participants identified for a study. The company's broader platform also supports trial feasibility assessment, decentralized trial delivery, and real-time safety monitoring.

Explore the full Patient Recruitment landscape

The companies above represent a portion of a much larger field.

Diligent's platform includes over 730 Patient Recruitment Vendors, with Vendor qualification data available on demand. Book a demo to explore Diligent's full vendor discovery database.

This article is intended as an informational overview of vendors operating in this space. Inclusion on this list does not constitute an endorsement, recommendation, or qualification by Diligent.